3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents

Details for Australian Patent Application No. 2008272693 (hide)

Owner AstraZeneca AB

Inventors Dumas, Jacques; Hill, Pamela; Basarab, Gregory Steven

Agent Davies Collison Cave

Pub. Number AU-A-2008272693

PCT Pub. Number WO2009/004382

Priority 60/947,654 02.07.07 US

Filing date 1 July 2008

Wipo publication date 8 January 2009

International Classifications

A61K 31/5383 (2006.01)

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07F 7/10 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2009/004382 Priority application(s): WO2009/004382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008272709-Phantom for imaging apparatuses

2008272690-Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates